ARTICLE | Clinical News
Idelvion albutrepenonacog alfa regulatory update
October 10, 2016 7:00 AM UTC
CSL said Japan approved Idelvion albutrepenonacog alfa for bleeding in hemophilia B patients. The product is indicated as routine prophylaxis to prevent or reduce the frequency of bleeding episodes; o...